Cookies help us run our site more efficiently.

By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information or to customize your cookie preferences.

‘They Try to Keep People Quiet’: an Epidemic of Antipsychotic Drugs in Nursing Homes

News Feed
Thursday, September 19, 2024

Mississippi consistently ranks in the top five in the nation for its rates of antipsychotic drugging in nursing homes, data from the federal government shows. More than one in five nursing home residents in the United States is given powerful and mind-altering antipsychotic drugs. That’s more than 10 times the rate of the general population – despite the fact that the conditions antipsychotics treat do not become more common with age. “The national average tells us that there are still a large number of older residents who are inappropriately being prescribed antipsychotics,” explained Dr. Michael Wasserman, a geriatrician and former CEO of the largest nursing home chain in California. “The Mississippi numbers can not rationally be explained,” continued Wasserman, who has served on several panels for the federal government and was a lead delegate in the 2005 White House Conference on Aging. “They are egregious.”The state long-term care ombudsman, Lisa Smith, declined to comment for this story.Hank Rainer, who has worked in the nursing home industry in Mississippi as a licensed certified social worker for 40 years, said the problem is two-fold: Nursing homes not being equipped to care for large populations of mentally ill adults, as well as misdiagnosing behavioral symptoms of dementia as psychosis. Both result in drugging the problem away with medications like antipsychotics, he said. Antipsychotics are a special class of psychotropics designed to treat psychoses accompanied by hallucinations and paranoia, such as schizophrenia. They have also been found to be helpful in treating certain symptoms of Tourette syndrome and Huntington’s disease, two neurological diseases. All of these conditions are predominantly diagnosed in early adulthood.The drugs come with a “black box warning,” the highest safety-related warning the Food and Drug Administration doles out, that cautions against using them in individuals with dementia. The risks of using them in patients with Alzheimer’s and other forms of dementia include death.Yet more than a decade after a federal initiative to curb antipsychotic drugging in nursing homes began, 94% of nursing homes in Mississippi – the state with the highest rate of deaths from Alzheimer’s disease – had antipsychotic drug rates in the double digits.Long-term care advocates and industry experts have long said that the exponentially higher number of nursing home residents on these drugs – 21% in the country and 26% in the state – is indicative of a deeper and darker problem: the substandard way America cares for its elders. “If the nursing homes don’t have enough staff, they try to keep people quiet, so they give them sedatives or antipsychotics,” said gerontologist and nursing home expert Charlene Harrington. And the problem, she emphasized, isn’t going away. “Over the last 20 years we’ve had more and more corporations involved and bigger and bigger chains, and 70% are for-profit, and they’re really not in it to provide health care,” Harrington said. “… It’s a way to make money. And that’s been allowed because the state doesn’t have the money to set up their own facilities.” ‘It’s just not right to give someone a drug they don’t need’ On a late Thursday morning in August, Ritchie Anne Keller, director of nursing at Vicksburg Convalescent Center, pointed out a resident falling asleep on one of the couches on the second floor of the nursing home.The resident, who nurses said was previously lively and would comment on the color of Keller’s scrubs every day, had just gotten back from another clinical inpatient setting where she was put on a slew of new drugs – including antipsychotics. One or more of them may be working, Keller explained, but the nursing staff would need to eliminate the drugs and then reintroduce them, if needed, to find the path of least medication. “How do you know which ones are helping her,” Keller asked, “when you got 10 of them?”The home, which boasts the second-lowest rate of antipsychotic drug use in the state, is led by two women who have worked there for decades.Keller has been at the nursing home since 1994 and entered her current position in 2004. Vicksburg Convalescent’s administrator, Amy Brown, has been at the home for over 20 years. Low turnover and high staffing levels are two of the main reasons the home has been able to keep such a low rate of antipsychotic drug use, according to Keller. These two measures allow staff to be rigorous about meeting individual needs and addressing behavioral issues through non-medicated intervention when possible, she explained.Keller said she often sees the effects of unnecessary drugging, and it happens because facilities don’t take the time to get to the root cause of a behavior. “We see (residents) go to the hospital, they may be combative because they have a UTI or something, and (the hospital staff) automatically put them on antipsychotics,” she said.Urinary tract infections in older adults can cause delirium and exacerbate dementia.It’s important to note, said Wasserman, that Vicksburg and other Mississippi nursing homes with the lowest rates are not at zero. Medicine is always a judgment call, he argued, which is why incentivizing nursing homes to bring their rates down to 0% or even 2% could be harmful. Schizophrenia is the only mental illness CMS will not penalize nursing home facilities for treating with antipsychotics in its quality care ratings. However, there are other FDA-approved uses, like bipolar disorder. “As a physician, a geriatrician, I have to use my clinical judgment on what I think is going to help a patient,” Wasserman said. “And sometimes, that clinical judgment might actually have me using an antipsychotic in the case of someone who doesn’t have a traditional, FDA-approved diagnosis.”In order to allow doctors the freedom to prescribe these drugs to individuals for whom they can drastically improve quality of life, Wasserman says the percentage of residents on antipsychotics can have some flexibility, but averages should stay in the single digits. When 20 to 30% of nursing home residents are on these drugs, that means a large portion of residents are on them unnecessarily, putting them at risk of deadly side effects, Wasserman explained. “But also, it’s just not right to give someone a drug they don’t need,” he said.Experts have long said that staffing is one of the strongest predictors in quality of care – including freedom from unnecessary medication – which makes a recent federal action requiring a minimum staffing level for nursing homes a big deal. The Biden administration finalized the first-ever national minimum staffing rule for nursing homes in April. The requirements will be phased in over two to three years for non-rural facilities and three to five years for rural facilities. In Mississippi, all but two of the 200 skilled nursing facilities – those licensed to provide medical care from registered nurses – would need to increase staffing levels under the standards, according to data analyzed by Mississippi Today, USA TODAY and Big Local News at Stanford University. Even Vicksburg Convalescent Center, which has a five-star rating on CMS’ Care Compare site and staffs “much above average,” will need to increase its staffing under the new regulations. Mississippi homes with the highest antipsychotic rates The six nursing homes with the highest antipsychotic rates in the state include three state-run nursing homes that share staff – including psychiatrists and licensed certified social workers – with the state psychiatric hospital, as well as three private, for-profit nursing homes in the Delta. The three Delta nursing homes are Ruleville Nursing and Rehabilitation Center in Ruleville, Oak Grove Retirement Home in Duncan, and Cleveland Nursing and Rehabilitation Center in Cleveland. All have percentages of schizophrenic residents between 26 and 43%, according to CMS data.Ruleville, a for-profit nursing home, had the highest rates of antipsychotic drugging in the state at 84% the last quarter of 2023. Slightly more than a third – or 39% – of the home’s residents had a schizophrenia diagnosis, and nearly half are 30-64 years old. New York-based Donald Denz and Norbert Bennett own both Ruleville Nursing and Rehabilitation Center and Cleveland Nursing and Rehabilitation Center.CMS rated the Ruleville facility as one out of five stars – or “much below average” – partly due to its rates of antipsychotic drugging. But G. Taylor Wilson, an attorney for the nursing home, cited the facility’s high percentages of depression, bipolar and non-schizophrenic psychoses as the reason for its high rate of antipsychotic drug use, and said that all medications are a result of a physician or psychiatric nurse practitioner’s order. While CMS has identified high antipsychotic drug rates as indicative of potential overmedication, Ruleville appears to be an exception, though it’s not clear why it accepts so many mentally ill residents or why its residents skew younger. It is unclear what, if any, special training Ruleville staff has in caring for people with mental illness. Wilson did say the home contracts with a group specializing in psychiatric services and sends residents to inpatient and outpatient psychiatric facilities when needed.There is no special designation or training required by the state for homes that have high populations of schizophrenic people or residents with other mental illnesses. Nursing homes must conduct a pre-admission screening to ensure they have the services needed for each admitted resident, according to the Health Department. An official with the State Health Department, which licenses and oversees nursing homes, said there are more private nursing homes that care for people with mental illness now because of a decrease in state-run mental health services and facilities.“Due to the lack of options for many individuals who suffer from mental illness, Mississippi is fortunate that we have facilities willing to care for them,” said State Health Department Assistant Senior Deputy Melissa Parker in an emailed statement to Mississippi Today. However, the Health Department cited Ruleville Nursing and Rehabilitation Center in May after a resident was allegedly killed by his roommate. The resident who allegedly killed his roommate had several mental health diagnoses, according to the report. The state agency said that the facility for months neglected to provide “appropriate person-centered behavioral interventions” to him, and that this negligence caused the resident’s death and placed other residents in danger. Wilson, the attorney for Ruleville, said his clients disagree with the state agency’s findings.“The supposed conclusions reached by the (state agency) regarding Ruleville’s practices are not fact; they are allegations which Ruleville strongly disputes,” he said. Oversight of nursing homes is limited In 2011, U.S. Inspector General Daniel Levinson said “government, taxpayers, nursing home residents, as well as their families and caregivers should be outraged – and seek solutions” in a brief following an investigative report that kickstarted the movement against overprescription of antipsychotics in nursing homes.“It was pretty striking,” said Richard Mollot, executive director of the Long Term Care Community Coalition, a nonprofit advocacy group dedicated to improving the lives of elderly and disabled people in residential facilities. “The Office of the Inspector General … They’re pretty conservative people. They don’t just come out and say that the public should be outraged by something.”That landmark report showed that 88% of Medicare claims for atypical antipsychotics – the primary class of antipsychotics used today – were for residents diagnosed with dementia. The black box warning cautioning against use in elderly residents with dementia was introduced six years earlier in 2005.But the problem persists today – and experts cite lack of oversight as one of the leading causes. “CMS has had that whole initiative to try to reduce antipsychotics, and it’s been 10 years, and basically, they’ve had no impact,” Harrington said. “Partly because they’re just not enforcing it. Surveyors are not giving citations … So, the practice just goes on.”In Mississippi, 52 nursing homes were cited 55 times in the last five years for failing to keep elderly residents free of unnecessary psychotropics, according to State Health Department data. Barring specific complaints of abuse, nursing homes are generally inspected once a year, according to the State Health Department. In Mississippi, 54% of nursing home state surveyor positions were vacant in 2022, and 44% of the working surveyors had less than two years of experience. During an inspection, a sample group usually consisting of three to five residents is chosen based on selection from surveyors and the computer system. That means if a nursing home is cited for a deficiency affecting one resident, that’s one resident out of the sample group – not one resident in the entire facility. The state cited Bedford Care Center of Marion in 2019 for unnecessarily administering antipsychotics. The inspection report reveals that four months after a resident was admitted to the facility, he was prescribed an antipsychotic for “dementia with behaviors.”The resident’s wife said her husband started sleeping 20 hours a day after starting the medication, according to the inspection report, yet the nursing home continued to administer the drug at the same dose for six months. CMS mandates that facilities attempt to reduce dose reductions for residents on psychotropic drugs and incorporate behavioral interventions in an effort to discontinue these drugs, unless clinically contraindicated. The facility did not respond to a request for comment from Mississippi Today. Officials with the nursing home did not respond to a request for comment from Mississippi Today. These two incidents – and all citations for this deficiency in the last five years – were cited as “level 2,” meaning “no actual harm” as defined by federal guidelines. Facilities are not fined for these citations, and their quality care score is only minimally impacted. “If they don’t say there’s harm, then they can’t give a fine,” Harrington said. “And even when they do give fines, they’re usually so low they have no effect. A $3,000 fine is just the cost of doing business. They don’t pay any attention to it.”“Level 3” and “Level 4” are mostly used in extreme and unlikely situations, explained Angela Carpenter, director of long-term care at the State Health Department.“For example,” she said, a Level 4 would be “if a person was placed on Haldol (an antipsychotic), he began having seizures, they still continued to give him the Haldol, they didn’t do a dose reduction, and the person ended up dying of a heart attack with seizures when they didn’t have a seizure disorder.”“Actual harm” is supposed to also include psychosocial harm, according to federal guidelines, but Carpenter said psychosocial harm “can be very difficult to prove,” as it involves going back to the facility and doing multiple interviews to figure out what the individual was like before the drugs – not to mention many symptoms are attributed to the cognitive decline associated with the aging process instead of being seen as possible symptoms of medication. Experts say the bar for “harm” is far too high.“And that sends a message that ‘Well, you know, we gave them a drug that changes the way their brain works, and we did it unnecessarily, but you know, no harm’ – and that’s where I think the regulators really don’t have a good understanding of what is actually happening here,” said Tony Chicotel, an elder attorney in California. ‘Looking at the person as a whole’: More humane solutions Hank Rainer, a licensed certified social worker, has worked in Mississippi nursing homes for decades. Nursing homes contract with him to train social services staff in how best to support residents and connect them with services they need. Rainer believes there are several solutions to mitigating the state’s high rates of antipsychotic drugs. Those include training more physicians in geriatrics, increasing residents’ access to psychiatrists and licensed certified social workers, and creating more memory care units that care for people with dementia. The nation is currently facing a severe shortage of geriatricians, with roughly one geriatrician for every 10,000 older patients. The American Geriatrics Society estimates one geriatrician can care for about 700 patients. Because it’s rare for a nursing home to contract with a psychiatrist, most residents are prescribed medication – including for mental health disorders – by a nurse practitioner or family medicine doctor, neither of which have extensive training in psychiatry or geriatrics. Rainer also said having more licensed certified social workers in nursing homes would better equip homes to address residents’ issues holistically.“LCSWs are best suited to help manage behaviors in nursing homes and other settings, as they look at the person as a whole,” he said. “They don’t just carve out and treat a disease. They look at the person’s illness and behaviors in regard to the impact of environmental, social and economic influences as well as the physical illness.”That’s not to say, he added, that some residents might not benefit most from pharmacological interventions in tandem with behavioral interventions. Finally, creating more memory care units that have the infrastructure to care for dementia behaviors with non-medicated intervention is especially important, Rainer said, given the fact that antipsychotics not only do not treat dementia, but also pose a number of health risks to this population. Dementia behaviors are often mistaken for psychosis, Rainer said, and having trained staff capable of making the distinction can be lifesaving. He gave an example of an 85-year-old woman with dementia who kept asking for her father. The delusion that her father was still alive technically meets the criteria for psychosis, he said, and so untrained staff may think antipsychotic medication was an appropriate treatment. However, trained staff would know how to implement interventions like meaningful diversional activities or validation therapy prior to the use of medications, he continued. “The father may represent safety and they may not feel safe in the building because they don’t know anyone there,” Rainer said. “Or the father may represent home and security and warmth and they may not feel quite at home in the facility. You don’t ever agree that their dad is coming to get them. That is not validation therapy. But what you do is you try to key in under the emotional component and get them to talk about that, and redirect them at the same time.”With more people living longer with conditions such as Alzheimer’s, good dementia care is becoming increasingly more important. But first the nursing homes would need to find the staff, Chicotel said. As it stands, with the vast majority of nursing homes in the country staffing below expert recommendations – nearly all nursing homes would have to increase staffing under not-yet-implemented Biden regulations, which are less stringent than federal recommendations made in 2001 – non-pharmacological, resident-centered care is hard to come by. “Trying to anticipate needs in advance and meeting them, spending more time with people so they don’t feel so uncomfortable and distressed and scared – that’s a lot of human touch that unfortunately is a casualty when facilities are understaffed,” Chicotel explained.This story was originally published by Mississippi Today and distributed through a partnership with The Associated Press.Copyright 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.Photos You Should See - July 2024

Data from the federal government shows that Mississippi consistently ranks in the top five in the nation for its rates of antipsychotic drugging in nursing homes

Mississippi consistently ranks in the top five in the nation for its rates of antipsychotic drugging in nursing homes, data from the federal government shows.

More than one in five nursing home residents in the United States is given powerful and mind-altering antipsychotic drugs. That’s more than 10 times the rate of the general population – despite the fact that the conditions antipsychotics treat do not become more common with age.

“The national average tells us that there are still a large number of older residents who are inappropriately being prescribed antipsychotics,” explained Dr. Michael Wasserman, a geriatrician and former CEO of the largest nursing home chain in California.

“The Mississippi numbers can not rationally be explained,” continued Wasserman, who has served on several panels for the federal government and was a lead delegate in the 2005 White House Conference on Aging. “They are egregious.”

The state long-term care ombudsman, Lisa Smith, declined to comment for this story.

Hank Rainer, who has worked in the nursing home industry in Mississippi as a licensed certified social worker for 40 years, said the problem is two-fold: Nursing homes not being equipped to care for large populations of mentally ill adults, as well as misdiagnosing behavioral symptoms of dementia as psychosis.

Both result in drugging the problem away with medications like antipsychotics, he said.

Antipsychotics are a special class of psychotropics designed to treat psychoses accompanied by hallucinations and paranoia, such as schizophrenia. They have also been found to be helpful in treating certain symptoms of Tourette syndrome and Huntington’s disease, two neurological diseases. All of these conditions are predominantly diagnosed in early adulthood.

The drugs come with a “black box warning,” the highest safety-related warning the Food and Drug Administration doles out, that cautions against using them in individuals with dementia. The risks of using them in patients with Alzheimer’s and other forms of dementia include death.

Yet more than a decade after a federal initiative to curb antipsychotic drugging in nursing homes began, 94% of nursing homes in Mississippi – the state with the highest rate of deaths from Alzheimer’s disease – had antipsychotic drug rates in the double digits.

Long-term care advocates and industry experts have long said that the exponentially higher number of nursing home residents on these drugs – 21% in the country and 26% in the state – is indicative of a deeper and darker problem: the substandard way America cares for its elders.

“If the nursing homes don’t have enough staff, they try to keep people quiet, so they give them sedatives or antipsychotics,” said gerontologist and nursing home expert Charlene Harrington.

And the problem, she emphasized, isn’t going away.

“Over the last 20 years we’ve had more and more corporations involved and bigger and bigger chains, and 70% are for-profit, and they’re really not in it to provide health care,” Harrington said. “… It’s a way to make money. And that’s been allowed because the state doesn’t have the money to set up their own facilities.”

‘It’s just not right to give someone a drug they don’t need’

On a late Thursday morning in August, Ritchie Anne Keller, director of nursing at Vicksburg Convalescent Center, pointed out a resident falling asleep on one of the couches on the second floor of the nursing home.

The resident, who nurses said was previously lively and would comment on the color of Keller’s scrubs every day, had just gotten back from another clinical inpatient setting where she was put on a slew of new drugs – including antipsychotics.

One or more of them may be working, Keller explained, but the nursing staff would need to eliminate the drugs and then reintroduce them, if needed, to find the path of least medication.

“How do you know which ones are helping her,” Keller asked, “when you got 10 of them?”

The home, which boasts the second-lowest rate of antipsychotic drug use in the state, is led by two women who have worked there for decades.

Keller has been at the nursing home since 1994 and entered her current position in 2004. Vicksburg Convalescent’s administrator, Amy Brown, has been at the home for over 20 years.

Low turnover and high staffing levels are two of the main reasons the home has been able to keep such a low rate of antipsychotic drug use, according to Keller. These two measures allow staff to be rigorous about meeting individual needs and addressing behavioral issues through non-medicated intervention when possible, she explained.

Keller said she often sees the effects of unnecessary drugging, and it happens because facilities don’t take the time to get to the root cause of a behavior.

“We see (residents) go to the hospital, they may be combative because they have a UTI or something, and (the hospital staff) automatically put them on antipsychotics,” she said.

Urinary tract infections in older adults can cause delirium and exacerbate dementia.

It’s important to note, said Wasserman, that Vicksburg and other Mississippi nursing homes with the lowest rates are not at zero. Medicine is always a judgment call, he argued, which is why incentivizing nursing homes to bring their rates down to 0% or even 2% could be harmful.

Schizophrenia is the only mental illness CMS will not penalize nursing home facilities for treating with antipsychotics in its quality care ratings. However, there are other FDA-approved uses, like bipolar disorder.

“As a physician, a geriatrician, I have to use my clinical judgment on what I think is going to help a patient,” Wasserman said. “And sometimes, that clinical judgment might actually have me using an antipsychotic in the case of someone who doesn’t have a traditional, FDA-approved diagnosis.”

In order to allow doctors the freedom to prescribe these drugs to individuals for whom they can drastically improve quality of life, Wasserman says the percentage of residents on antipsychotics can have some flexibility, but averages should stay in the single digits.

When 20 to 30% of nursing home residents are on these drugs, that means a large portion of residents are on them unnecessarily, putting them at risk of deadly side effects, Wasserman explained.

“But also, it’s just not right to give someone a drug they don’t need,” he said.

Experts have long said that staffing is one of the strongest predictors in quality of care – including freedom from unnecessary medication – which makes a recent federal action requiring a minimum staffing level for nursing homes a big deal.

The Biden administration finalized the first-ever national minimum staffing rule for nursing homes in April. The requirements will be phased in over two to three years for non-rural facilities and three to five years for rural facilities.

In Mississippi, all but two of the 200 skilled nursing facilities – those licensed to provide medical care from registered nurses – would need to increase staffing levels under the standards, according to data analyzed by Mississippi Today, USA TODAY and Big Local News at Stanford University.

Even Vicksburg Convalescent Center, which has a five-star rating on CMS’ Care Compare site and staffs “much above average,” will need to increase its staffing under the new regulations.

Mississippi homes with the highest antipsychotic rates

The six nursing homes with the highest antipsychotic rates in the state include three state-run nursing homes that share staff – including psychiatrists and licensed certified social workers – with the state psychiatric hospital, as well as three private, for-profit nursing homes in the Delta.

The three Delta nursing homes are Ruleville Nursing and Rehabilitation Center in Ruleville, Oak Grove Retirement Home in Duncan, and Cleveland Nursing and Rehabilitation Center in Cleveland. All have percentages of schizophrenic residents between 26 and 43%, according to CMS data.

Ruleville, a for-profit nursing home, had the highest rates of antipsychotic drugging in the state at 84% the last quarter of 2023. Slightly more than a third – or 39% – of the home’s residents had a schizophrenia diagnosis, and nearly half are 30-64 years old.

New York-based Donald Denz and Norbert Bennett own both Ruleville Nursing and Rehabilitation Center and Cleveland Nursing and Rehabilitation Center.

CMS rated the Ruleville facility as one out of five stars – or “much below average” – partly due to its rates of antipsychotic drugging.

But G. Taylor Wilson, an attorney for the nursing home, cited the facility’s high percentages of depression, bipolar and non-schizophrenic psychoses as the reason for its high rate of antipsychotic drug use, and said that all medications are a result of a physician or psychiatric nurse practitioner’s order.

While CMS has identified high antipsychotic drug rates as indicative of potential overmedication, Ruleville appears to be an exception, though it’s not clear why it accepts so many mentally ill residents or why its residents skew younger.

It is unclear what, if any, special training Ruleville staff has in caring for people with mental illness. Wilson did say the home contracts with a group specializing in psychiatric services and sends residents to inpatient and outpatient psychiatric facilities when needed.

There is no special designation or training required by the state for homes that have high populations of schizophrenic people or residents with other mental illnesses. Nursing homes must conduct a pre-admission screening to ensure they have the services needed for each admitted resident, according to the Health Department.

An official with the State Health Department, which licenses and oversees nursing homes, said there are more private nursing homes that care for people with mental illness now because of a decrease in state-run mental health services and facilities.

“Due to the lack of options for many individuals who suffer from mental illness, Mississippi is fortunate that we have facilities willing to care for them,” said State Health Department Assistant Senior Deputy Melissa Parker in an emailed statement to Mississippi Today.

However, the Health Department cited Ruleville Nursing and Rehabilitation Center in May after a resident was allegedly killed by his roommate.

The resident who allegedly killed his roommate had several mental health diagnoses, according to the report. The state agency said that the facility for months neglected to provide “appropriate person-centered behavioral interventions” to him, and that this negligence caused the resident’s death and placed other residents in danger.

Wilson, the attorney for Ruleville, said his clients disagree with the state agency’s findings.

“The supposed conclusions reached by the (state agency) regarding Ruleville’s practices are not fact; they are allegations which Ruleville strongly disputes,” he said.

Oversight of nursing homes is limited

In 2011, U.S. Inspector General Daniel Levinson said “government, taxpayers, nursing home residents, as well as their families and caregivers should be outraged – and seek solutions” in a brief following an investigative report that kickstarted the movement against overprescription of antipsychotics in nursing homes.

“It was pretty striking,” said Richard Mollot, executive director of the Long Term Care Community Coalition, a nonprofit advocacy group dedicated to improving the lives of elderly and disabled people in residential facilities. “The Office of the Inspector General … They’re pretty conservative people. They don’t just come out and say that the public should be outraged by something.”

That landmark report showed that 88% of Medicare claims for atypical antipsychotics – the primary class of antipsychotics used today – were for residents diagnosed with dementia. The black box warning cautioning against use in elderly residents with dementia was introduced six years earlier in 2005.

But the problem persists today – and experts cite lack of oversight as one of the leading causes.

“CMS has had that whole initiative to try to reduce antipsychotics, and it’s been 10 years, and basically, they’ve had no impact,” Harrington said. “Partly because they’re just not enforcing it. Surveyors are not giving citations … So, the practice just goes on.”

In Mississippi, 52 nursing homes were cited 55 times in the last five years for failing to keep elderly residents free of unnecessary psychotropics, according to State Health Department data.

Barring specific complaints of abuse, nursing homes are generally inspected once a year, according to the State Health Department. In Mississippi, 54% of nursing home state surveyor positions were vacant in 2022, and 44% of the working surveyors had less than two years of experience.

During an inspection, a sample group usually consisting of three to five residents is chosen based on selection from surveyors and the computer system. That means if a nursing home is cited for a deficiency affecting one resident, that’s one resident out of the sample group – not one resident in the entire facility.

The state cited Bedford Care Center of Marion in 2019 for unnecessarily administering antipsychotics. The inspection report reveals that four months after a resident was admitted to the facility, he was prescribed an antipsychotic for “dementia with behaviors.”

The resident’s wife said her husband started sleeping 20 hours a day after starting the medication, according to the inspection report, yet the nursing home continued to administer the drug at the same dose for six months.

CMS mandates that facilities attempt to reduce dose reductions for residents on psychotropic drugs and incorporate behavioral interventions in an effort to discontinue these drugs, unless clinically contraindicated.

The facility did not respond to a request for comment from Mississippi Today.

Officials with the nursing home did not respond to a request for comment from Mississippi Today.

These two incidents – and all citations for this deficiency in the last five years – were cited as “level 2,” meaning “no actual harm” as defined by federal guidelines. Facilities are not fined for these citations, and their quality care score is only minimally impacted.

“If they don’t say there’s harm, then they can’t give a fine,” Harrington said. “And even when they do give fines, they’re usually so low they have no effect. A $3,000 fine is just the cost of doing business. They don’t pay any attention to it.”

“Level 3” and “Level 4” are mostly used in extreme and unlikely situations, explained Angela Carpenter, director of long-term care at the State Health Department.

“For example,” she said, a Level 4 would be “if a person was placed on Haldol (an antipsychotic), he began having seizures, they still continued to give him the Haldol, they didn’t do a dose reduction, and the person ended up dying of a heart attack with seizures when they didn’t have a seizure disorder.”

“Actual harm” is supposed to also include psychosocial harm, according to federal guidelines, but Carpenter said psychosocial harm “can be very difficult to prove,” as it involves going back to the facility and doing multiple interviews to figure out what the individual was like before the drugs – not to mention many symptoms are attributed to the cognitive decline associated with the aging process instead of being seen as possible symptoms of medication.

Experts say the bar for “harm” is far too high.

“And that sends a message that ‘Well, you know, we gave them a drug that changes the way their brain works, and we did it unnecessarily, but you know, no harm’ – and that’s where I think the regulators really don’t have a good understanding of what is actually happening here,” said Tony Chicotel, an elder attorney in California.

‘Looking at the person as a whole’: More humane solutions

Hank Rainer, a licensed certified social worker, has worked in Mississippi nursing homes for decades. Nursing homes contract with him to train social services staff in how best to support residents and connect them with services they need.

Rainer believes there are several solutions to mitigating the state’s high rates of antipsychotic drugs. Those include training more physicians in geriatrics, increasing residents’ access to psychiatrists and licensed certified social workers, and creating more memory care units that care for people with dementia.

The nation is currently facing a severe shortage of geriatricians, with roughly one geriatrician for every 10,000 older patients. The American Geriatrics Society estimates one geriatrician can care for about 700 patients.

Because it’s rare for a nursing home to contract with a psychiatrist, most residents are prescribed medication – including for mental health disorders – by a nurse practitioner or family medicine doctor, neither of which have extensive training in psychiatry or geriatrics.

Rainer also said having more licensed certified social workers in nursing homes would better equip homes to address residents’ issues holistically.

“LCSWs are best suited to help manage behaviors in nursing homes and other settings, as they look at the person as a whole,” he said. “They don’t just carve out and treat a disease. They look at the person’s illness and behaviors in regard to the impact of environmental, social and economic influences as well as the physical illness.”

That’s not to say, he added, that some residents might not benefit most from pharmacological interventions in tandem with behavioral interventions.

Finally, creating more memory care units that have the infrastructure to care for dementia behaviors with non-medicated intervention is especially important, Rainer said, given the fact that antipsychotics not only do not treat dementia, but also pose a number of health risks to this population.

Dementia behaviors are often mistaken for psychosis, Rainer said, and having trained staff capable of making the distinction can be lifesaving. He gave an example of an 85-year-old woman with dementia who kept asking for her father.

The delusion that her father was still alive technically meets the criteria for psychosis, he said, and so untrained staff may think antipsychotic medication was an appropriate treatment.

However, trained staff would know how to implement interventions like meaningful diversional activities or validation therapy prior to the use of medications, he continued.

“The father may represent safety and they may not feel safe in the building because they don’t know anyone there,” Rainer said. “Or the father may represent home and security and warmth and they may not feel quite at home in the facility. You don’t ever agree that their dad is coming to get them. That is not validation therapy. But what you do is you try to key in under the emotional component and get them to talk about that, and redirect them at the same time.”

With more people living longer with conditions such as Alzheimer’s, good dementia care is becoming increasingly more important.

But first the nursing homes would need to find the staff, Chicotel said.

As it stands, with the vast majority of nursing homes in the country staffing below expert recommendations – nearly all nursing homes would have to increase staffing under not-yet-implemented Biden regulations, which are less stringent than federal recommendations made in 2001 – non-pharmacological, resident-centered care is hard to come by.

“Trying to anticipate needs in advance and meeting them, spending more time with people so they don’t feel so uncomfortable and distressed and scared – that’s a lot of human touch that unfortunately is a casualty when facilities are understaffed,” Chicotel explained.

This story was originally published by Mississippi Today and distributed through a partnership with The Associated Press.

Copyright 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Photos You Should See - July 2024

Read the full story here.
Photos courtesy of

4 vaccines that are linked to a lower risk of dementia

Some vaccine-preventable diseases are linked to accelerated brain atrophy and increased dementia risk years down the line.

Vaccines don’t just protect us from infectious diseases or lessen their effects. Some are also associated with a reduced risk for dementia, research shows.“They’ll protect against these really potentially severe infections, especially in older adults, and preventing that alone is huge,” said Avram Bukhbinder, a resident physician at Massachusetts General Hospital in Boston who has conducted research on vaccines and dementia risk.“There seems to also be some kind of added benefit and ultimately it just adds a more compelling reason” to get routine vaccines, he said.Studies have found that many vaccines may be associated with a reduced risk of dementia — here are four of the most common ones with the strongest links.The flu shotAn estimated 47 million to 82 million people in the United States — about 13 to 24 percent of all people — caught influenza, or the flu, during the 2024-2025 season with 27,000 to 130,000 Americans dying as a result, according to preliminary data from the Centers for Disease Control and Prevention. (Flu season generally runs from October to May in North America.)Influenza and pneumonia — a potential complication of flu — are associated with five neurodegenerative diseases, including dementia and Parkinson’s disease, according to a 2023 study analyzing biobank data from over 400,000 people.“I don’t know how many times in the adult world we hear, ‘My loved one got flu, was in the hospital for a week or two, and it just was never the same.’ Like quickly went downhill from there,” Bukhbinder said.Many studies have found that flu vaccination is associated with a lower risk of dementia years later.In a 2022 study, Bukhbinder and his colleagues at the University of Texas Health Science Center at Houston examined a large health database of over 1.8 million adults ages 65 and over. They found that those who received at least one flu vaccine were 40 percent less likely to develop Alzheimer’s — the most common form of dementia — during the next four years.Getting the flu vaccine was also associated with a 17 percent reduction in dementia risk in a 2024 study of over 70,000 participants.The CDC recommends all people over 6 months old get annual flu shots, typically in September or October.Fewer than half of Americans typically get their flu vaccine each season.The shingles vaccineThe shingles vaccine has the strongest evidence for reducing the risk of dementia with multiple large-scale studies in the past two years corroborating the results of older studies.In one 2025 study, researchers tracked more than 280,000 adults in Wales and found that the shingles vaccine was linked with reducing dementia risk by 20 percent over a seven-year period.“There may be potential additional benefits beyond the protection that the vaccine provides for a particular condition,” said Pascal Geldsetzer, an assistant professor of medicine at the Stanford University School of Medicine and the senior author of the study. “So, that’s only an additional reason to get vaccinated.”A subsequent study examining over 100,000 patients in Australia similarly found that getting vaccinated for shingles was associated with reduced dementia risk.If you are eligible, you should probably get a shingles vaccine regardless of its chances of reducing your dementia risk. The vaccine reduces the reactivation of the varicella-zoster virus, which causes chicken pox in childhood and remains dormant in nerve cells afterward. When reactivated in adulthood, the virus manifests as shingles, which is characterized by a burning, painful rash and can sometimes cause lifelong chronic pain conditions or serious complications in a subset of people who get it.The CDC recommends two doses of a shingles vaccine for adults 50 and older or those 19 and older with a weakened immune system; 36 percent of eligible Americans got vaccinated in 2022.The RSV vaccineRespiratory syncytial virus, or RSV, is a common respiratory virus that can cause mild, cold-like symptoms in most people, but may cause severe infections in children as well as adults ages 65 and older. (The virus is the leading cause of hospitalization among American infants and causes an estimated 10o to 300 deaths in children under 5, and 6,000 to 10,000 deaths in people 65 or older, every year in the U.S.)A recent study tracking over 430,000 people found that the RSV vaccine (as well as the shingles vaccine) was associated with a reduced risk of dementia over 18 months compared with those who received the flu vaccine.The CDC recommends all adults ages 75 and older, as well as adults older than 50 at higher risk of RSV, get the vaccine.The Tdap vaccineSeveral studies have reported that the vaccine against tetanus, diphtheria and pertussis (or whooping cough), or Tdap, is associated with a reduced risk of dementia.One 2021 study with over 200,000 patients reported that older adults who received both the shingles and Tdap vaccines had further reduced risk of dementia compared with those who only received one of the vaccines.The CDC recommends routine Tdap vaccination for all adolescents and a booster for adults every 10 years. In 2022, about 30 percent of adults ages 19-64 who could be assessed had received a Tdap vaccine.How vaccines may reduce dementia riskResearch has shown that severe infections, including flu, herpes and respiratory tract infections, are linked to accelerated brain atrophy and increased risk of dementia years down the line.“We think it’s the uncontrolled kind of systemic inflammation that’s probably contributing to that,” Bukhbinder said. “And it’s very likely that they had the underlying Alzheimer’s or other dementia pathology already, but the inflammation is what pushed them over the edge.”Geldsetzer said that the varicella-zoster virus, which causes shingles, has the most clear biological links because it hibernates in our nervous system and can more directly affect the brain. (Getting a chicken pox vaccine in childhood can prevent this virus from taking hold in the first place.)Though different vaccines are linked to reduced dementia risk, there are inherent limitations to how the research was conducted. The link is associational, not causal, because the people who get vaccines may be different from those who don’t.For example, it could be that “those who are on average more health-motivated, have better health behaviors, are the ones who decide to get vaccinated,” Geldsetzer said. Even though researchers try to account for these confounding variables, it is not possible to fully filter out differences in health behaviors associated with dementia risk.But recent studies hint at a stronger link between the shingles vaccine and dementia-risk reduction. This research takes advantage of “natural experiments” because of arbitrary dates that the governments of Wales and Australia set for shingles vaccine eligibility; those born immediately before and after the eligibility date are probably not different and can be more directly compared. And when they are, those who got the shingles vaccines had lower risk of dementia, said Geldsetzer, who was an author on the Wales and Australia studies and is raising money to fund a randomized controlled trial.There are two broad biological hypotheses for how vaccines are linked to reduced dementia risk. Vaccines could reduce the risk of getting sick and infection severity, which have been linked to increased dementia risk.“I feel confident that that’s part of the story, but it’s not the whole story,” Bukhbinder said.Another, not mutually exclusive possibility is that the vaccine itself may activate the immune system in a beneficial way. Vaccination “may be honing or refining the immune system’s response,” Bukhbinder said.There’s “good evidence that what happens outside of the brain … seems to actually affect the inside pretty robustly,” Bukhbinder said.How to keep up-to-date on vaccines and reduce dementia riskVaccinations, like all medical treatments, can have some risks and side effects, so it is important to speak with your doctor about your particular health needs.However, “I would say by and far the benefits of getting these vaccinations almost incomparably outweigh the risks,” Bukhbinder said.In addition, 45 percent of dementia cases could be delayed or prevented with lifestyle and environmental changes, according to the 2024 Lancet Commission report on dementia.Do you have a question about human behavior or neuroscience? Email BrainMatters@washpost.com and we may answer it in a future column.

Almost 1.5m homes could be built on brownfield sites in England, report finds

Exclusive: CPRE study suggests housebuilding targets can be met without encroaching on green belt landAlmost 1.5m new homes could be built on brownfield sites in England to avoid encroaching on green belt and meet the government target for housing growth by the end of this parliament, new figures suggest.But despite the scale of brownfield land available, developers are pushing to build on green land, including increased housebuilding on and adjacent to areas of outstanding natural beauty. Continue reading...

Almost 1.5m new homes could be built on brownfield sites in England to avoid encroaching on green belt and meet the government target for housing growth by the end of this parliament, new figures suggest.But despite the scale of brownfield land available, developers are pushing to build on green land, including increased housebuilding on and adjacent to areas of outstanding natural beauty.More than half of the brownfield areas – 54% – have planning permission already and are considered deliverable under the national planning policy framework guidelines within five years. These provide shovel-ready sites for 790,000 properties – more than half of the government’s 1.5m target.The countryside charity CPRE, which obtained the figures from councils all over England, is calling for the government to enforce its brownfield-first approach in order to fulfil the target of 1.5m new homes by the end of this parliament in the face of increasing development on green land.Roger Mortlock, the chief executive officer of the CPRE, said: “If the government is serious about a brownfield-first approach, it needs more teeth … We know that large developers favour building on our countryside, with more identikit, car-dependent executive homes being needlessly built on our countryside.”Analysis of the 2023 and 2024 brownfield registers kept by local authorities across England reveals the number of sites available has risen by 16% in the 12 months to 2024.There are 30,257 sites available, covering 32,884 hectares (81,223 acres) that local councils have identified as suitable for 1.49m dwellings, the data shows.Brownfield sites are a constantly renewing resource, the CPRE says. They include former retail areas in town centres, abandoned factories and redundant commercial buildings.Across England, from the south-west, through London to the Midlands and the north, this means there are enough brownfield areas to build the 1.5m new homes the government is promising without encroaching on green belt or precious natural landscapes.The data appears to contradict statements made by the prime minister, Keir Starmer, who has claimed it is impossible to build 1.5m new homes on brownfield land. “We must be honest, we cannot build the homes Britain needs without also releasing some land currently classed as green belt,” he said.Developers appear to be exploiting the failure by this government and previous administrations to mandate a brownfield-first approach.Between 2021 and 2022, 46% of development took place on green belt, or green sites, unnecessarily bulldozing nature and ecosystems, the CPRE said. New developments in the countryside were being built all the time, they added.“A new approach to local housing numbers has massively increased the target in many rural areas without any evidence of local need and without the infrastructure to support new communities,” said Mortlock. As well as damaging nature, the developments were not sustainable, he said, as they had no transport or community infrastructure, forcing people into their cars.Brownfield sites are available in the key areas where the government is focusing its housebuilding growth. These include London, where there are enough brownfield sites to build 535,000 homes; the south-east, where there are sufficient areas for 190,814 homes; and the West Midlands, where brownfield sites exist to build 191,004 homes.The CPRE says the government should apply ambitious and enforceable targets for affordable and social homes on shovel-ready brownfield sites.The new figures come as ministers are finalising the new planning and infrastructure bill, which rolls back environmental laws in what the government says is a ripping up of red tape to speed up approvals.Despite some amendments, the bill is still considered a regression of environmental rules by the government’s own environmental watchdog, the Office for Environmental Protection.The Home Builders Federation said: “Not all brownfield land is viable for development, with many sites facing a range of complex challenges. Suitability depends on the land’s ownership, remediation requirements, location, accessibility and attractiveness to potential residents.“Many will be sites that are attractive to retail or other commercial developers who, by not being subject to the taxes and requirements placed on residential developers, can often bid more for land.”The government was approached for comment.

Government required to create plan to protect greater glider in major legal win for Wilderness Society

Murray Watt agrees recovery plans for greater glider, ghost bat, lungfish and sandhill dunnart were not made by successive governmentsFollow our Australia news live blog for latest updatesGet our breaking news email, free app or daily news podcastThe federal environment minister, Murray Watt, has conceded that successive governments acted unlawfully when they failed to create mandatory recovery plans for native species threatened with extinction in a major legal win for one of Australia’s largest environmental organisations.The Wilderness Society has been successful in federal court proceedings it launched in March that sought to compel the minister to make recovery plans for species including the greater glider and the ghost bat. Continue reading...

The federal environment minister, Murray Watt, has conceded that successive governments acted unlawfully when they failed to create mandatory recovery plans for native species threatened with extinction in a major legal win for one of Australia’s largest environmental organisations.The Wilderness Society has been successful in federal court proceedings it launched in March that sought to compel the minister to make recovery plans for species including the greater glider and the ghost bat.In a court settlement, reached Friday, the government agreed mandatory recovery plans for four threatened species – the greater glider, the ghost bat, the lungfish and the sandhill dunnart – had not been made and successive ministers had exceeded the timeframe in which the plans were required to be created and put in force.The government also agreed that recovery plans for seven other threatened species – including the baudin’s and carnaby’s black cockatoos – that were previously said to have expired or “sunsetted”, would remain in force.Sign up: AU Breaking News email“Today is a win for threatened wildlife across Australia. After decades of neglect by government after government, we took to the courts to fight for Australia’s pride and joy – its diverse and world-important environment,” the Wilderness Society biodiversity policy and campaign manager, Sam Szoke-Burke, said.“The resolution of this case provides much-needed certainty for Australia’s iconic plants and animals, some of whom have been waiting for over a decade for a legally required recovery roadmap to give them a better chance at surviving extinction.”Recovery plans set out actions needed to bring species back from the brink of extinction and put them on a better trajectory.Under Australia’s national environmental laws, the environment minister decides whether a species requires a recovery plan or not. If the minister decides a species does require one, the plan must usually be made within three years.Once a recovery plan is enacted, the minister must not make decisions that would be considered contrary to its goals and actions.The Wilderness Society’s legal action followed long-held concerns about a backlog of unfinished and undeveloped plans for species including the greater glider, which has required a recovery plan since 2016 but has no plan in place.Years of reporting by Guardian Australia has highlighted the failure by successive governments to make recovery plans within the required time frames. An auditor general’s report in 2022 found only 2% of recovery plans had been completed within their statutory timeframe since 2013.In 2020 the federal environment department told a Senate estimates hearing that 170 plants, animals and habitats were waiting for recovery plans.To reduce the backlog, the previous Coalition government had the threatened species scientific committee reassess whether some species still required a plan and, in 2022, scrapped the requirement for almost 200 plants, animals and habitats.In 2022, freedom of information documents obtained by Guardian Australia revealed concerns within the federal environment department that 372 recovery plans covering 575 species and ecosystems were due to expire by the end of 2023.skip past newsletter promotionSign up to Breaking News AustraliaGet the most important news as it breaksPrivacy Notice: Newsletters may contain information about charities, online ads, and content funded by outside parties. If you do not have an account, we will create a guest account for you on theguardian.com to send you this newsletter. You can complete full registration at any time. For more information about how we use your data see our Privacy Policy. We use Google reCaptcha to protect our website and the Google Privacy Policy and Terms of Service apply.after newsletter promotionLast week before it reached its settlement with the Wilderness Society, the government updated its recovery plans webpage to state that recovery plans were exempt from sunsetting.Szoke-Burke said the legal victory set an important precedent that showed recovery plans were not optional.“The government now knows that when the law says the minister must do something, that doesn’t mean maybe,” he said.“This outcome should set a new tone for how the government treats Australia’s iconic and unique natural environment. It’s time to prioritise nature, or face legal action and further community outcry.”Ellen Maybery, a lawyer at Environmental Justice Australia which acted for the Wilderness Society in the proceedings, said the win “forces the government to act”.“For decades, successive governments have failed to follow their own laws and deliver these vital recovery plans. The court has now compelled the environment minister to do his job and make the required plans,” she said.Guardian Australia has sought comment from Watt.

Trump will reportedly link autism to pain reliever Tylenol - but many experts are sceptical

Some studies have suggested an association between the two, but experts say there is no causal relationship.

Trump officials are expected to link the use of pain reliever Tylenol in pregnant women to autism, according to US media reports. At an Oval Office event on Monday, the US president will reportedly advise pregnant women in the US to only take Tylenol, known as paracetamol elsewhere, to relieve high fevers.At the Charlie Kirk memorial service on Sunday, Trump said he had an "amazing" announcement coming on autism, saying it was "out of control" but they might now have a reason why.Some studies have shown a link between pregnant women taking Tylenol and autism, but these findings are inconsistent and do not prove the drug causes autism. Tylenol is a popular brand of pain relief medication sold in the United States, Canada and some other countries. Its active ingredient is acetaminophen, which is called paracetamol outside North America.Tylenol maker Kenvue has defended the use of the drug in pregnant women.In a statement to the BBC, it said: "We believe independent, sound science clearly shows that taking acetaminophen does not cause autism. We strongly disagree with any suggestion otherwise and are deeply concerned with the health risk this poses for expecting mothers."Acetaminophen is the safest pain reliever option for pregnant women, it added, and without it, women face a dangerous choice between suffering through conditions like fever or use riskier alternatives.The BBC has contacted the Department of Health and Human Services (HHS) for comment. In April, the leader of HHS, Robert F Kennedy Jr, pledged "a massive testing and research effort" to determine the cause of autism in five months.But experts have cautioned that finding the causes of autism - a complex syndrome that has been researched for decades - would not be simple. The widely held view of researchers is that there is no single cause of autism, which is thought to be the result of a complex mix of genetic and environmental factors.The American College of Obstetrics and Gynecology said doctors across the country have consistently identified Tylenol as one of the only safe pain relievers for pregnant women."[S]tudies that have been conducted in the past, show no clear evidence that proves a direct relationship between the prudent use of acetaminophen during any trimester and fetal developmental issues," the group has said. The drug is recommended by other major medical groups as well as other governments around the world. In August, a review of research led by the dean of Harvard University's Chan School of Public Health found that children may be more likely to develop autism and other neurodevelopmental disorders when exposed to Tylenol during pregnancy. The researchers argued some steps should be taken to limit use of the drug, but said the pain reliever was still important for treating maternal fever and pain, which can also have negative effects for children. But another study, published in 2024, found no relationship between exposure to Tylenol and autism. "There is no robust evidence or convincing studies to suggest there is any causal relationship," said Monique Botha, a professor in social and developmental psychology at Durham University. Dr Botha added that pain relief for pregnant women was "woefully lacking", with Tylenol being one of the only safe options for the population. Autism diagnoses have increased sharply since 2000, and by 2020 the rate among 8-year-olds reached 2.77%, according to the US Centers for Disease Control and Prevention (CDC).Scientists attribute at least part of the rise to increased awareness of autism and an expanding definition of the disorder. Researchers have also been investigating environmental factors.In the past, Kennedy has offered debunked theories about the rising rates of autism, blaming vaccines despite a lack of evidence.

CNN: Costa Rica Shifts From “Switzerland” to Drug Transit Route

CNN en Español published an article noting that Costa Rica has gone from being “the Switzerland of Central America” to becoming a key route for drug trafficking.“ Renowned for its peaceful and stable environment… today it faces a different reality, as reflected in the report published on Monday by the United States government,” the article said, […] The post CNN: Costa Rica Shifts From “Switzerland” to Drug Transit Route appeared first on The Tico Times | Costa Rica News | Travel | Real Estate.

CNN en Español published an article noting that Costa Rica has gone from being “the Switzerland of Central America” to becoming a key route for drug trafficking.“ Renowned for its peaceful and stable environment… today it faces a different reality, as reflected in the report published on Monday by the United States government,” the article said, referring to the fact that the country was named one of the main transit routes or centers of illicit drug production for fiscal year 2026. Costa Rican Security Minister Mario Zamora told CNN that the most important thing is that the country maintains its certification from the United States as a reliable partner in the fight against drugs in the region. The official added that Costa Rica, like the rest of the Central American nations, shares the geographical reality of being a “transit route between producer and consumer countries.” He insisted this is not something new, since the country has been part of the transit route for more than 35 years. Zamora told CNN that “there is no news,” emphasizing again that, like its neighbors, Costa Rica’s role as a transit country is practically impossible to avoid. “But what is new is the recognition as a trusted partner that Secretary of Security Kristi Noem gave us during her visit to Costa Rica,” he stressed. CNN reported that during a tour of the area surrounding San José, the capital, several citizens said they were not surprised that the United States included Costa Rica on its list of major drug transit countries. “It’s too obvious; the authorities can’t be everywhere. Years ago, it was quiet, but not now. Governments have to come together to counteract this,” said one of the citizens interviewed. What is most concerning, the media outlet highlighted, is that reports indicate shootouts between criminal groups are resulting in collateral victims. According to the Judicial Investigation Agency (OIJ), as of September 16, there have been 25 victims: 17 men and 8 women. From January to September 16, the OIJ recorded 614 homicides, of which 404 were related to score-settling and threats. Authorities attribute these crimes to clashes between criminal gangs fighting over drug sales territories. CNN noted that Costa Rica’s image as the “Switzerland of Central America” was forged in the second half of the 20th century, built on the consolidation of a welfare state, the expansion of social rights, the strength of democratic institutions, and remarkable leadership in environmental conservation. However, that image is now being tarnished by the escalation of violence linked to drug trafficking. The post CNN: Costa Rica Shifts From “Switzerland” to Drug Transit Route appeared first on The Tico Times | Costa Rica News | Travel | Real Estate.

Suggested Viewing

Join us to forge
a sustainable future

Our team is always growing.
Become a partner, volunteer, sponsor, or intern today.
Let us know how you would like to get involved!

CONTACT US

sign up for our mailing list to stay informed on the latest films and environmental headlines.

Subscribers receive a free day pass for streaming Cinema Verde.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.